Clinical trial
A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control
NCT02111746 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 20, 2013
- Completion date
- June 30, 2017
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.